Top Companies in Genomics Market

The global genomics market is projected to reach USD 85.09 billion by 2030 from USD 47.07 billion in 2025, registering a CAGR of 12.6% between 2025 and 2030. Market growth can be attributed to increasing government funding for genomics projects, rising applications of NGS in chronic disorders, advancements in NGS platforms, and growing applications of genomics. Furthermore, the increasing use of genomics in precision medicine further contributes to market growth.

The global genomics market is competitive, with Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Laboratory Corporation of America Holdings (US), and QIAGEN (Germany) accounting for 40–50% of the market share globally. These market players have adopted growth strategies, such as product launches, acquisitions, agreements, collaborations, and geographical expansions, to strengthen their position in the global genomics market.

To know about the assumptions considered for the study download the pdf brochure

In June 2024, Danaher Corporation launched an HIV panel to advance virology research, representing innovation in its NGS portfolio. In July 2024, Thermo Fisher Scientific launched a novel pre-transplant risk assessment assay to assess the risk of kidney transplant rejection.

Illumina, Inc. (US)

Illumina is a global leader in genome sequencing solutions, enabling researchers to explore the functions of genetic variants and underlying biological processes. The company’s product portfolio encompasses consumables, integrated systems, and analytical instruments designed to simplify genetic analysis. Genomics products are primarily offered under Illumina’s Equipment and Consumables segment, while genomics-related services are delivered through its Service and Other Revenue segment. Illumina’s consistent investment in research and development has strengthened its innovation capabilities, enhanced product accuracy, and expanded the range of genomic applications. A key example is the Illumina Complete Long Read Prep, Human, the first product developed using its proprietary Illumina Complete Long Read technology, launched in March 2023. This solution enables high-performance, long-read human whole-genome sequencing and is compatible with the NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 sequencing systems.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific Inc. is a leading global provider of medical equipment, analytical instruments, reagents and consumables, software, and related services. The company operates in the genomics market primarily through its Life Science Solutions segment, with products and services offered under its Genetic Sciences and Biosciences businesses. With operations spanning over 100 countries, Thermo Fisher maintains a strong international presence. The company pursues both organic and inorganic growth strategies to strengthen its market position and expand its technological capabilities. For example, in June 2024, Thermo Fisher launched Stellar MS, a high-performance mass spectrometry platform that integrates speed and sensitivity to advance translational omics research.

Danaher Corporation (US)

Danaher Corporation manufactures and commercializes medical, industrial, and commercial products and services. The company offers genomics products through its subsidiaries, Integrated DNA Technologies, Inc., Cepheid, Inc., and Beckman Coulter, which operates under the Life Sciences and Diagnostics segments. The company provides products & services to pharmaceutical and biotechnology companies, colleges & universities, research institutes, and government bodies (including government testing & diagnostic centers) through its sales and distribution office network.

The company invests in innovation and implements strategies such as product launches, partnerships, and collaborations. For instance, in May 2024, Integrated DNA Technologies, a subsidiary of Danaher, partnered with Molecular Health to integrate its NGS capabilities and extend genomic profiling.

Market Ranking

The genomics market is competitive, with seven leading players collectively holding 40–50% of the market share. Thermo Fisher Scientific maintains a strong presence with a comprehensive portfolio of sequencing platforms, genetic analyzers, reagents, and consumables, supported by advanced bioinformatics tools and a global supply and service network. The company’s broad customer base across research, clinical, and applied markets strengthens its leadership position. Danaher Corporation (Cytiva and Pall Biotech) is among the key participants, offering a wide range of genomic and molecular biology solutions, including sample preparation, nucleic acid purification, analytical instrumentation, and automation technologies. The company’s integrated systems enable seamless workflows across research and diagnostic genomics applications. Illumina, Inc. remains a dominant player in sequencing technologies, with a strong portfolio spanning sequencing instruments, library preparation kits, and data analysis platforms that support high-throughput and precision genomics research. F. Hoffmann-La Roche Ltd. holds a significant position through its molecular diagnostics, sequencing, and digital PCR solutions, underpinned by expertise in clinical genomics and personalized medicine. Other market players contribute to the remaining 50–60% of the total market share, which is distributed among regional players, component suppliers, and specialized genomics technology providers focusing on single-cell analysis, spatial genomics, and gene editing applications. Market trends in 2024 indicate strong momentum driven by advances in sequencing accuracy, declining costs, and the integration of AI and automation to enhance genomic data analysis and clinical translation.

Related Reports:

Genomics Market by Product (Reagents, Kits, Instruments), Services (Genome Profiling, Bioinformatics), Technology (Sequencing, PCR, ISH, Flow Cytometry), Study Type (Epigenomics), Application (Drug Discovery, Diagnostics, Agri) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com